ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

In Brief: Names Submitted For NIH Deputy Director; Gottesman Leads Genome Project Temporarily

May 8, 1992

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

ACS Offers New Grants to Physicians

September 7, 1984

City of Hope CEO Michael Friedman: Cancer Centers Must Adapt; “Not Losing Sleep” Over Sequestration

April 5, 2013

June Panel Meeting Dropped

June 3, 1977